CRSP
CRISPR Therapeutics AG
Company overview
- Market capitalization
- $5.23B
- Employees
- 393
- Latest publication
- 2026-09-29
About CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting allogeneic chimeric antigen receptor T cell for autoimmune indications and oncology. The company's lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemoglobinopathies in which a patient's hematopoietic stem and progenitor cells are edited to produce high levels of fetal hemoglobin in red blood cells. It also develops CAR T cell therapies, including CTX112 targeting cluster of differentiation 19 (CD19) and CTX131 targeting CD70 for oncology and autoimmune indications; CTX310 and CTX320, in vivo gene editing to address the cardiovascular disease by disrupting the validated targets angiopoietin-like protein 3 and lipoprotein; and CTX211, an allogeneic, gene-edited, hypoimmune stem cell-derived product candidate for the treatment of T1D. It has strategic partnerships with Vertex Pharmaceuticals Incorporated. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20242024-12-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20212021-06-30 · USD | Q4 20192019-12-31 · USD | Q3 20192019-09-30 · USD | Q2 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10,181,000USD | 35,000,000USD | 200,000,000USD | 0USD | 900,202,000USD | 77,016,000USD | 211,928,000USD | 318,000USD |
| Research Development | 67,152,000USD | 82,155,000USD | 95,144,000USD | 90,698,000USD | 82,332,000USD | 48,761,000USD | 57,246,000USD | 39,533,000USD |
| Selling General Administrative | 17,553,000USD | 18,124,000USD | 16,479,000USD | 18,291,000USD | 28,806,000USD | 17,272,000USD | 15,519,000USD | 15,768,000USD |
| General And Administrative Expenses | 17,553,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 127,450,000USD | 99,588,000USD | 110,417,000USD | 108,989,000USD | 110,639,000USD | 17,272,000USD | 72,765,000USD | 55,301,000USD |
| Operating Income | -117,269,000USD | -64,588,000USD | 69,583,000USD | -132,411,000USD | 762,618,000USD | 10,983,000USD | 139,163,000USD | -54,983,000USD |
| Total Other Income Expense Net | 27,075,000USD | 27,977,000USD | 19,997,000USD | 20,671,000USD | 750,000USD | 19,563,000USD | -466,000USD | 1,369,000USD |
| Interest Expense | 3,324,000USD | — | 17,793,000USD | — | — | — | — | — |
| Income Before Tax | -90,194,000USD | -36,611,000USD | 89,580,000USD | -111,740,000USD | 763,368,000USD | 30,546,000USD | 138,697,000USD | -53,614,000USD |
| Income Tax Expense | 960,000USD | 700,000USD | 233,000USD | 412,000USD | 4,143,000USD | 4,000USD | 274,000USD | 85,000USD |
| Net Income | -91,154,000USD | -37,311,000USD | 89,347,000USD | -112,152,000USD | 759,225,000USD | 30,542,000USD | 138,423,000USD | -53,699,000USD |
| Cost Of Revenue | — | 4,151,000USD | 20,000,000USD | 23,422,000USD | 26,945,000USD | 48,761,000USD | 57,246,000USD | 39,533,000USD |
| Gross Profit | — | 35,000,000USD | 180,000,000USD | -23,422,000USD | 873,257,000USD | 28,255,000USD | 154,682,000USD | -39,215,000USD |
| Tax Provision | — | 700,000USD | 233,000USD | 412,000USD | 4,143,000USD | 4,000USD | 274,000USD | 85,000USD |
| Net Income From Continuing Ops | — | -37,311,000USD | 89,347,000USD | -112,152,000USD | 759,225,000USD | 30,542,000USD | 138,423,000USD | -53,699,000USD |
| Ebit | — | -36,611,000USD | 89,580,000USD | -111,740,000USD | 763,368,000USD | 10,983,000USD | 139,163,000USD | -54,983,000USD |
| Ebitda | — | -31,769,000USD | 94,480,000USD | -106,815,000USD | 767,021,000USD | 12,415,000USD | 140,446,000USD | -53,785,000USD |
| Depreciation And Amortization | — | 4,842,000USD | 4,900,000USD | 4,925,000USD | 3,653,000USD | 1,432,000USD | 1,283,000USD | 1,198,000USD |
| Reconciled Depreciation | — | 4,842,000USD | 4,900,000USD | 4,925,000USD | 3,653,000USD | 1,432,000USD | 1,283,000USD | 1,198,000USD |
| Unclassified Operating Expenses | — | — | -1,206,000USD | — | — | -48,761,000USD | — | — |
| Non Operating Income Net Other | — | — | — | — | 750,000USD | — | -466,000USD | 1,369,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | 759,225,000USD | 30,542,000USD | 138,423,000USD | -53,699,000USD |
| Interest Income | — | — | — | — | — | — | 3,430,000USD | 1,012,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 913,081,000USD | 289,590,000USD | 3,124,000USD | 40,997,000USD | 5,164,000USD | 247,000USD | 0USD |
| Cost Of Revenue | 101,178,000USD | 179,362,000USD | 113,773,000USD | 69,800,000USD | 42,238,000USD | 12,573,000USD | 1,513,000USD |
| Gross Profit | 913,081,000USD | 289,590,000USD | 3,124,000USD | -28,803,000USD | -37,074,000USD | -12,326,000USD | -1,513,000USD |
| Research Development | 438,633,000USD | 179,362,000USD | 113,773,000USD | 69,800,000USD | 42,238,000USD | 12,573,000USD | 1,513,000USD |
| Selling General Administrative | 102,802,000USD | 63,488,000USD | 48,294,000USD | 35,845,000USD | 31,056,000USD | 13,403,000USD | 5,114,000USD |
| Total Operating Expenses | 539,553,000USD | 242,850,000USD | 162,067,000USD | 105,645,000USD | 73,294,000USD | 25,976,000USD | 6,627,000USD |
| Operating Income | 373,528,000USD | 46,740,000USD | -158,943,000USD | -64,648,000USD | -68,130,000USD | -25,729,000USD | -6,627,000USD |
| Interest Expense | 23,956,000USD | 25,291,000USD | 0USD | 0USD | 8,050,000USD | 108,000USD | 0USD |
| Income Before Tax | 379,531,000USD | 67,306,000USD | -164,428,000USD | -66,608,000USD | -22,718,000USD | -25,821,000USD | -6,863,000USD |
| Income Tax Expense | 1,870,000USD | 448,000USD | 553,000USD | 1,749,000USD | 484,000USD | 7,000USD | -63,000USD |
| Tax Provision | 1,870,000USD | 448,000USD | 553,000USD | 1,749,000USD | 484,000USD | 7,000USD | — |
| Net Income | 377,661,000USD | 66,858,000USD | -164,981,000USD | -68,357,000USD | -23,202,000USD | -25,828,000USD | -6,800,000USD |
| Net Income From Continuing Ops | 377,661,000USD | 66,858,000USD | -164,981,000USD | -68,357,000USD | -23,202,000USD | -25,828,000USD | -6,800,000USD |
| Ebit | 373,528,000USD | 46,740,000USD | -158,943,000USD | -64,648,000USD | -14,668,000USD | -25,713,000USD | -6,627,000USD |
| Ebitda | 391,481,000USD | 51,465,000USD | -155,424,000USD | -61,624,000USD | -13,668,000USD | -25,586,000USD | -6,589,000USD |
| Depreciation And Amortization | 17,953,000USD | 4,725,000USD | 3,519,000USD | 3,024,000USD | 1,000,000USD | 127,000USD | 38,000USD |
| Reconciled Depreciation | 17,953,000USD | 4,725,000USD | 3,519,000USD | 3,024,000USD | — | — | — |
| Total Other Income Expense Net | 6,003,000USD | 20,566,000USD | -5,485,000USD | -1,960,000USD | 45,412,000USD | -92,000USD | -236,000USD |
| Non Operating Income Net Other | 6,003,000USD | 20,566,000USD | -5,485,000USD | -1,960,000USD | 53,462,000USD | — | — |
| Net Income Applicable To Common Shares | 377,661,000USD | 66,858,000USD | -164,981,000USD | -68,357,000USD | -23,177,000USD | -25,503,000USD | -7,009,000USD |
| Interest Income | — | 5,467,000USD | 4,275,000USD | 1,763,000USD | 44,582,000USD | 108,000USD | — |
| Net Interest Income | — | — | 0USD | — | -8,050,000USD | — | — |
| Minority Interest | — | — | — | — | -25,000USD | -27,000USD | 143,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,650,770,000USD | 2,725,820,000USD | 2,265,243,000USD | 2,245,308,000USD | 2,029,711,000USD | 2,166,102,000USD | 2,242,034,000USD | 2,256,130,000USD |
| Cash And Equivalents | 291,337,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 2,364,352,000USD | 2,441,785,000USD | 1,975,828,000USD | 1,915,710,000USD | 1,724,751,000USD | 1,855,285,000USD | 1,903,826,000USD | 1,935,645,000USD |
| Short Term Investments | 2,073,015,000USD | 2,018,477,000USD | 1,628,269,000USD | 1,629,213,000USD | 1,527,619,000USD | 1,620,101,000USD | 1,605,569,000USD | 1,709,975,000USD |
| Long Term Investments | 0USD | — | — | 28,412,000USD | — | — | 0USD | 0USD |
| Total Current Assets | 2,371,770,000USD | 2,448,362,000USD | 1,975,828,000USD | 1,929,092,000USD | 1,733,666,000USD | 1,867,611,000USD | 1,937,132,000USD | 1,943,891,000USD |
| Other Current Assets | 7,418,000USD | 6,577,000USD | 9,843,000USD | 13,382,000USD | 8,915,000USD | 12,326,000USD | 8,306,000USD | 8,246,000USD |
| Other Non Current Assets | 37,711,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 904,219,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 132,896,000USD | 136,286,000USD | 149,120,000USD | 118,957,000USD | 104,362,000USD | 119,447,000USD | 87,782,000USD | 89,810,000USD |
| Other Current Liabilities | 16,982,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 6,221,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,746,551,000USD | 1,814,556,000USD | 1,921,813,000USD | 1,915,982,000USD | 1,711,125,000USD | 1,829,160,000USD | 1,932,080,000USD | 1,939,658,000USD |
| Total Equity Including Noncontrolling Interest | 1,746,551,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 15,189,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 233,660,000USD | 240,846,000USD | 247,575,000USD | 255,490,000USD | 262,567,000USD | 269,703,000USD | 277,554,000USD | 284,828,000USD |
| Accounts Payable | 11,307,000USD | 13,647,000USD | 11,138,000USD | 11,798,000USD | 9,753,000USD | 13,064,000USD | 14,709,000USD | 15,578,000USD |
| Short Term Debt | 18,646,000USD | 18,612,000USD | 18,578,000USD | 18,256,000USD | 18,027,000USD | 17,506,000USD | 17,288,000USD | 16,883,000USD |
| Common Stock | 3,130,000USD | 3,115,000USD | 3,087,000USD | 3,013,000USD | 2,794,000USD | 2,721,000USD | 2,698,000USD | 2,684,000USD |
| Retained Earnings | -2,161,636,000USD | -2,070,482,000USD | -1,947,551,000USD | -1,816,938,000USD | -1,710,497,000USD | -1,501,948,000USD | -1,365,952,000USD | -1,328,641,000USD |
| Accumulated Other Comprehensive Income | -4,629,000USD | -1,941,000USD | 4,821,000USD | 4,986,000USD | 4,041,000USD | 4,135,000USD | 1,840,000USD | 10,565,000USD |
| Total Liab | — | 911,264,000USD | 343,430,000USD | 329,326,000USD | 318,586,000USD | 336,942,000USD | 309,954,000USD | 316,472,000USD |
| Other Current Liab | — | 88,683,000USD | 103,633,000USD | 84,182,000USD | 73,738,000USD | 84,615,000USD | 51,489,000USD | 52,028,000USD |
| Capital Stock | — | 3,115,000USD | 3,087,000USD | 3,013,000USD | 2,794,000USD | 2,721,000USD | 2,698,000USD | 2,684,000USD |
| Cash | — | 423,308,000USD | 355,188,000USD | 290,011,000USD | 197,132,000USD | 235,184,000USD | 298,257,000USD | 225,670,000USD |
| Current Deferred Revenue | — | 15,344,000USD | 15,771,000USD | 1,295,000USD | 2,129,000USD | 3,021,000USD | 3,845,000USD | 4,483,000USD |
| Net Debt | — | 364,334,000USD | 39,726,000USD | 113,781,000USD | 18,320,000USD | -15,826,000USD | -74,564,000USD | 1,875,000USD |
| Short Long Term Debt Total | — | 787,642,000USD | 394,914,000USD | 403,792,000USD | 215,452,000USD | 219,358,000USD | 223,693,000USD | 227,545,000USD |
| Long Term Debt | — | 585,470,000USD | — | — | — | — | — | — |
| Property Plant Equipment Gross | — | 336,188,000USD | 338,627,000USD | 341,103,000USD | 344,166,000USD | 346,671,000USD | 349,826,000USD | 352,619,000USD |
| Common Stock Shares Outstanding | — | 96,051,228shares | 89,925,109shares | 91,305,337shares | 87,069,690shares | 85,938,720shares | 85,464,252shares | 85,235,000shares |
| Non Current Assets Total | — | 277,458,000USD | 279,572,000USD | 316,216,000USD | 296,045,000USD | 298,491,000USD | 304,902,000USD | 312,239,000USD |
| Non Current Liabilities Total | — | 774,978,000USD | 194,310,000USD | 210,369,000USD | 214,224,000USD | 217,495,000USD | 222,172,000USD | 226,661,999USD |
| Non Current Liabilities Other | — | 5,948,000USD | 6,142,000USD | 5,278,000USD | 4,476,000USD | 3,320,000USD | 3,444,000USD | 3,677,000USD |
| Non Currrent Assets Other | — | 36,612,000USD | 279,572,000USD | 32,314,000USD | 2,872,000USD | 28,788,000USD | 27,348,000USD | 27,411,000USD |
| Net Working Capital | — | 2,312,076,000USD | 1,836,551,000USD | 1,810,135,000USD | 1,629,304,000USD | 1,748,164,000USD | 1,849,350,000USD | 1,854,081,000USD |
| Unclassified Non Current Liabilities | — | 183,560,000USD | 188,168,000USD | 205,091,000USD | 209,748,000USD | 214,175,000USD | 218,728,000USD | 222,984,999USD |
| Unclassified Equity | — | 3,880,749,000USD | 3,858,369,000USD | 3,721,908,000USD | 3,411,993,000USD | 3,321,531,000USD | 3,290,796,000USD | 3,252,366,000USD |
| Net Receivables | — | — | 0USD | 0USD | 0USD | 0USD | 25,000,000USD | 0USD |
| Unclassified Non Current Assets | — | — | -247,575,000USD | — | 30,606,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | 3,426,000USD | — | 1,241,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,265,243,000USD | 2,242,034,000USD | 2,229,571,000USD | 2,243,057,000USD | 2,751,877,000USD | 1,827,966,000USD | 1,066,752,000USD | 489,016,000USD |
| Other Current Assets | 9,843,000USD | 8,306,000USD | 14,386,000USD | 37,708,000USD | 38,079,000USD | 15,443,000USD | 6,977,000USD | 9,658,000USD |
| Total Liab | 343,430,000USD | 309,954,000USD | 346,768,000USD | 367,578,000USD | 352,417,000USD | 163,732,000USD | 127,327,000USD | 96,821,000USD |
| Total Stockholder Equity | 1,921,813,000USD | 1,932,080,000USD | 1,882,803,000USD | 1,875,479,000USD | 2,399,460,000USD | 1,664,234,000USD | 939,425,000USD | 392,195,000USD |
| Other Current Liab | 103,633,000USD | 51,489,000USD | 50,914,000USD | 77,837,000USD | 91,898,000USD | 60,989,000USD | 41,130,000USD | 221,000USD |
| Common Stock | 3,087,000USD | 2,698,000USD | 2,497,000USD | 2,441,000USD | 2,391,000USD | 2,277,000USD | 1,847,000USD | 1,584,000USD |
| Capital Stock | 3,087,000USD | 2,698,000USD | 2,497,000USD | 2,441,000USD | 2,391,000USD | 2,277,000USD | 1,847,000USD | 1,584,000USD |
| Retained Earnings | -1,947,551,000USD | -1,365,952,000USD | -999,700,000USD | -846,090,000USD | -195,915,000USD | -573,576,000USD | -224,711,000USD | -291,569,000USD |
| Cash | 355,188,000USD | 298,257,000USD | 389,477,000USD | 211,885,000USD | 923,031,000USD | 1,168,620,000USD | 943,771,000USD | 456,649,000USD |
| Cash And Short Term Investments | 1,975,828,000USD | 1,903,826,000USD | 1,693,692,000USD | 1,815,318,000USD | 2,379,129,000USD | 1,690,333,000USD | 943,771,000USD | 456,649,000USD |
| Total Current Assets | 1,985,671,000USD | 1,937,132,000USD | 1,908,078,000USD | 1,853,026,000USD | 2,417,513,000USD | 1,716,620,000USD | 987,547,000USD | 466,395,000USD |
| Total Current Liabilities | 149,120,000USD | 87,782,000USD | 108,791,000USD | 121,107,000USD | 119,883,000USD | 94,259,000USD | 57,106,000USD | 27,746,000USD |
| Current Deferred Revenue | 15,771,000USD | 3,845,000USD | 4,105,000USD | 12,323,000USD | 1,010,999USD | 2,341,000USD | 960,000USD | 57,780,000USD |
| Net Debt | 39,726,000USD | -74,564,000USD | -150,845,000USD | 32,136,000USD | -698,001,000USD | -1,107,191,000USD | -891,232,000USD | -456,649,000USD |
| Short Term Debt | 18,578,000USD | 17,288,000USD | 15,625,000USD | 15,842,000USD | 12,158,000USD | 11,362,000USD | 8,489,000USD | 35,324,000USD |
| Short Long Term Debt Total | 394,914,000USD | 223,693,000USD | 238,632,000USD | 244,021,000USD | 225,030,000USD | 61,429,000USD | 52,539,000USD | — |
| Short Term Investments | 1,628,269,000USD | 1,605,569,000USD | 1,304,215,000USD | 1,603,433,000USD | 1,456,098,000USD | 521,712,999USD | — | — |
| Net Receivables | 0USD | 25,000,000USD | 200,000,000USD | 11,200,000USD | 305,000USD | 10,844,000USD | 99,000USD | 88,000USD |
| Accounts Payable | 11,138,000USD | 14,709,000USD | 38,147,000USD | 27,428,000USD | 14,816,000USD | 9,094,000USD | 5,944,000USD | 5,069,000USD |
| Property Plant Equipment Net | 247,575,000USD | 277,554,000USD | 305,938,000USD | 320,555,000USD | 312,035,000USD | 93,025,000USD | 72,832,000USD | 18,500,000USD |
| Property Plant Equipment Gross | 338,627,000USD | 349,826,000USD | 359,371,000USD | 163,634,000USD | 137,575,000USD | 93,025,000USD | 72,832,000USD | 18,500,000USD |
| Accumulated Other Comprehensive Income | 4,821,000USD | 1,840,000USD | 1,912,999USD | -15,647,000USD | -5,067,000USD | -83,000USD | 7,000USD | -8,000USD |
| Common Stock Shares Outstanding | 89,925,109shares | 84,359,126shares | 79,220,930shares | 77,746,575shares | 80,393,496shares | 65,949,672shares | 56,932,798shares | 47,964,368shares |
| Non Current Assets Total | 279,572,000USD | 304,902,000USD | 321,493,000USD | 390,031,000USD | 334,364,000USD | 111,346,000USD | 79,205,000USD | 22,621,000USD |
| Non Current Liabilities Total | 194,310,000USD | 222,172,000USD | 237,976,999USD | 246,470,999USD | 232,534,000USD | 69,473,000USD | 70,221,000USD | 69,075,000USD |
| Non Current Liabilities Other | 6,142,000USD | 3,444,000USD | 958,000USD | 5,969,000USD | 232,534,000USD | 69,473,000USD | 14,395,000USD | 243,000USD |
| Non Currrent Assets Other | 31,997,000USD | 27,348,000USD | 13,566,000USD | 16,275,000USD | 22,204,000USD | 18,141,000USD | 6,138,000USD | 3,832,000USD |
| Net Working Capital | 1,836,551,000USD | 1,849,350,000USD | 1,799,287,000USD | 1,731,919,000USD | 2,297,630,000USD | 1,622,361,000USD | 930,441,000USD | 438,649,000USD |
| Unclassified Non Current Liabilities | 188,168,000USD | 218,728,000USD | 237,018,999USD | 222,209,999USD | -19,662,000USD | -19,406,000USD | 29,655,000USD | -11,295,000USD |
| Unclassified Equity | 3,858,369,000USD | 3,290,796,000USD | 2,875,596,001USD | 2,732,397,000USD | 2,595,723,000USD | 2,233,402,000USD | 1,160,498,000USD | 680,661,000USD |
| Long Term Investments | — | 0USD | 1,973,000USD | 53,130,000USD | 0USD | — | — | — |
| Intangible Assets | — | — | 16,000USD | 71,000USD | 125,000USD | 180,000USD | 235,000USD | 289,000USD |
| Other Liab | — | — | — | 18,292,000USD | 19,662,000USD | 19,406,000USD | 26,171,000USD | 69,075,000USD |
| Other Assets | — | — | — | 16,275,000USD | 22,204,000USD | 18,141,000USD | 6,138,000USD | 3,832,000USD |
| Inventory | — | — | — | -11,200,000USD | — | — | 1USD | 1USD |
| Treasury Stock | — | — | — | -63,000USD | -63,000USD | -63,000USD | -63,000USD | -57,000USD |
| Net Tangible Assets | — | — | — | 1,875,479,000USD | 2,399,460,000USD | 1,664,054,000USD | 939,190,000USD | 391,906,000USD |
| Unclassified Non Current Assets | — | — | — | -16,275,000USD | -22,204,000USD | -18,141,000USD | -6,138,000USD | -3,832,000USD |
| Unclassified Current Liabilities | — | — | — | -12,323,000USD | — | 10,473,000USD | — | -70,648,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | 36,699,999USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 11,052,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 8,599,000USD |
| Stock Based Compensation | 33,640,000USD |
| Other Non Cash Items | 4,763,000USD |
| Change To Account Receivables | 0USD |
| Change To Liabilities | -14,373,000USD |
| Change In Working Capital | -15,461,000USD |
| Operating Cash Flow | -192,395,000USD |
| Capital Expenditures | -1,152,000USD |
| Net Investments | -768,135,000USD |
| Unclassified Investing Cash Flow | 302,885,000USD |
| Investing Cash Flow | -466,402,000USD |
| Common Stock Issuance | 14,460,000USD |
| Unclassified Financing Cash Flow | 584,628,000USD |
| Financing Cash Flow | 599,088,000USD |
| Effect Of Forex Changes On Cash | -26,000USD |
| Change In Cash | -59,735,000USD |
| End Cash Flow | 299,343,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -122,931,000USD | -130,613,000USD | -106,441,000USD | -208,549,000USD | -135,996,000USD | -37,311,000USD | -85,942,000USD | -126,408,000USD |
| Depreciation | 4,319,000USD | 5,661,000USD | 4,433,000USD | 4,649,000USD | 4,736,000USD | 4,842,000USD | 4,739,000USD | 4,845,000USD |
| Stock Based Compensation | 16,324,000USD | 18,076,000USD | 16,604,000USD | 17,607,000USD | 20,212,000USD | 21,947,000USD | 21,543,000USD | 23,672,000USD |
| Other Non Cash Items | 25,124,000USD | -8,314,000USD | -10,139,000USD | 88,925,000USD | 2,253,000USD | -15,155,000USD | -6,897,000USD | -8,181,000USD |
| Change To Account Receivables | 0USD | 0USD | 0USD | 0USD | 25,000,000USD | -25,000,000USD | 0USD | 0USD |
| Change In Working Capital | -15,409,000USD | 22,637,000USD | 10,909,000USD | -16,512,000USD | 54,848,000USD | -24,354,000USD | -40,356,000USD | 10,490,000USD |
| Total Cash From Operating Activities | -108,897,000USD | -92,553,000USD | -84,634,000USD | -113,880,000USD | -53,947,000USD | -50,031,000USD | -106,913,000USD | -95,582,000USD |
| Capital Expenditures | -504,000USD | -517,000USD | -74,000USD | -117,000USD | -206,000USD | -254,000USD | -219,000USD | -707,000USD |
| Free Cash Flow | -109,401,000USD | -93,070,000USD | -84,708,000USD | -113,997,000USD | -54,153,000USD | -50,285,000USD | -107,132,000USD | -96,289,000USD |
| Investments | -410,239,000USD | 37,716,000USD | -119,226,000USD | 69,977,000USD | -19,755,000USD | 105,828,000USD | -161,604,000USD | -126,905,000USD |
| Total Cashflows From Investing Activities | -410,743,000USD | 37,199,000USD | -119,226,000USD | 69,977,000USD | -19,755,000USD | 105,828,000USD | -161,604,000USD | -126,905,000USD |
| Total Cash From Financing Activities | 591,908,000USD | 116,414,000USD | 296,766,000USD | 2,258,000USD | 10,588,000USD | 16,876,000USD | 9,640,000USD | -466,000USD |
| Issuance Of Capital Stock | 600,000,000USD | 111,491,000USD | 278,105,000USD | -22,000USD | 8,516,000USD | 14,959,000USD | 6,003,000USD | -1,012,000USD |
| Change In Cash | 68,520,000USD | 61,061,000USD | 92,879,000USD | -41,565,000USD | -63,073,000USD | 72,586,000USD | -258,802,000USD | -222,951,000USD |
| Begin Period Cash Flow | 355,188,000USD | 298,017,000USD | 205,138,000USD | 238,697,000USD | 309,776,000USD | 237,190,000USD | 495,992,000USD | 718,943,000USD |
| End Period Cash Flow | 423,708,000USD | 359,078,000USD | 298,017,000USD | 197,132,000USD | 246,703,000USD | 309,776,000USD | 237,190,000USD | 495,992,000USD |
| Other Cashflows From Investing Activities | -4,615,000USD | — | -9,700,000USD | -25,000,000USD | — | — | -20,385,000USD | -126,198,000USD |
| Other Cashflows From Financing Activities | 591,908,000USD | — | 18,661,000USD | -60,479,000USD | 2,072,000USD | 1,917,000USD | 3,637,000USD | 546,000USD |
| Unclassified Operating Cash Flow | -16,324,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | 4,615,000USD | — | 9,774,000USD | 25,117,000USD | — | — | 20,604,000USD | 126,905,000USD |
| Unclassified Financing Cash Flow | -600,000,000USD | 4,923,000USD | 206,852,000USD | -8,516,000USD | — | — | 5,537,000USD | — |
| Sale Purchase Of Stock | — | — | 71,253,000USD | 71,253,000USD | — | — | 466,000USD | -466,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -581,599,000USD | -366,252,000USD | -153,610,000USD | -650,175,000USD | 377,661,000USD | -348,865,000USD | 66,858,000USD | -164,981,000USD |
| Depreciation | 19,479,000USD | 19,259,000USD | 19,837,000USD | 24,172,000USD | 17,953,000USD | 9,184,000USD | 4,725,000USD | 3,519,000USD |
| Stock Based Compensation | 72,499,000USD | 86,567,000USD | 81,028,000USD | 97,947,000USD | 102,390,000USD | 66,018,000USD | 44,057,000USD | 34,985,000USD |
| Other Non Cash Items | 72,725,000USD | -38,618,000USD | -14,045,000USD | 12,470,000USD | 14,109,000USD | 1,857,000USD | -10,533,000USD | 15,413,000USD |
| Change To Account Receivables | 25,000,000USD | 175,000,000USD | -200,000,000USD | 305,000USD | -161,000USD | -45,000USD | -11,000USD | 2,538,000USD |
| Change In Working Capital | 71,882,000USD | 156,270,000USD | -193,585,000USD | 19,845,000USD | 26,859,000USD | 33,440,000USD | -48,430,000USD | 10,550,000USD |
| Total Cash From Operating Activities | -345,014,000USD | -142,774,000USD | -260,375,000USD | -495,741,000USD | 538,972,000USD | -238,366,000USD | 56,677,000USD | -96,239,000USD |
| Capital Expenditures | -914,000USD | -1,901,000USD | -9,470,000USD | -37,188,000USD | -81,705,000USD | -18,358,000USD | -6,684,000USD | -2,773,000USD |
| Free Cash Flow | -345,928,000USD | -144,675,000USD | -269,845,000USD | -532,929,000USD | 457,267,000USD | -256,724,000USD | 49,993,000USD | -99,012,000USD |
| Investments | -5,891,000USD | -280,481,000USD | 280,568,000USD | -258,655,000USD | -953,725,000USD | -522,812,000USD | 1,325,000USD | -2,773,000USD |
| Total Cashflows From Investing Activities | -31,805,000USD | -280,481,000USD | 374,647,000USD | -258,655,000USD | -1,035,430,000USD | -541,170,000USD | 1,325,000USD | -2,773,000USD |
| Total Cash From Financing Activities | 426,026,000USD | 331,984,000USD | 62,664,000USD | 38,592,000USD | 250,945,000USD | 1,016,152,000USD | 430,983,000USD | 315,934,000USD |
| Sale Purchase Of Stock | 71,253,000USD | — | — | 38,592,000USD | 250,945,000USD | 1,016,152,000USD | 430,983,000USD | -57,000USD |
| Issuance Of Capital Stock | 398,090,000USD | 300,695,000USD | 32,721,000USD | 970,000USD | 213,267,000USD | 982,289,000USD | 415,019,000USD | 307,053,000USD |
| Change In Cash | 49,302,000USD | -91,292,000USD | 177,592,000USD | -715,884,000USD | -245,524,000USD | 236,656,000USD | 489,000,000USD | 216,900,000USD |
| Begin Period Cash Flow | 309,776,000USD | 401,068,000USD | 211,885,000USD | 939,944,000USD | 1,185,468,000USD | 948,812,000USD | 459,812,000USD | 242,912,000USD |
| End Period Cash Flow | 359,078,000USD | 309,776,000USD | 389,477,000USD | 224,060,000USD | 939,944,000USD | 1,185,468,000USD | 948,812,000USD | 459,812,000USD |
| Other Cashflows From Investing Activities | -33,998,000USD | -23,183,000USD | -2,500,000USD | -221,467,000USD | -953,725,000USD | -522,812,000USD | 8,009,000USD | — |
| Other Cashflows From Financing Activities | 426,026,000USD | 31,289,000USD | 29,943,000USD | 37,622,000USD | 37,678,000USD | 33,863,000USD | 15,964,000USD | 8,938,000USD |
| Unclassified Investing Cash Flow | 8,998,000USD | 25,084,000USD | 106,049,000USD | 258,655,000USD | 953,725,000USD | 522,812,000USD | -1,325,000USD | 2,773,000USD |
| Unclassified Financing Cash Flow | -71,253,000USD | — | — | -37,622,000USD | -37,678,000USD | -33,863,000USD | -15,964,000USD | 307,053,000USD |
| Change To Inventory | — | — | 23,329,000USD | — | -37,514,000USD | -25,747,000USD | -5,025,000USD | 332,299,000USD |
| Change To Liabilities | — | — | — | 3,643,000USD | 32,209,000USD | 15,239,000USD | 30,008,000USD | 12,359,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -715,804,000USD | -245,513,000USD | 236,616,000USD | 488,985,000USD | 216,922,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | 4,275,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Collaboration Revenue | 10,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Grant | 181,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue | 1,000,000 | USD | 0001193125-26-204188 |
| Q1 2026Quarterly · 2026-03-31 | Product | Grant | 458,000 | USD | 0001193125-26-204188 |
| Q4 2025Quarterly · 2025-12-31 | Product | Collaboration Revenue | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Grant | 864,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenue | 0 | USD | 0001193125-26-048957 |
| FY 2025Yearly · 2025-12-31 | Product | Grant | 3,510,000 | USD | 0001193125-26-048957 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenue | 0 | USD | 0001193125-25-273337 |
| Q3 2025Quarterly · 2025-09-30 | Product | Grant | 889,000 | USD | 0001193125-25-273337 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenue | 0 | USD | 0000950170-25-102052 |
| Q2 2025Quarterly · 2025-06-30 | Product | Grant | 892,000 | USD | 0000950170-25-102052 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenue | 0 | USD | 0001193125-26-204188 |
| Q1 2025Quarterly · 2025-03-31 | Product | Grant | 865,000 | USD | 0001193125-26-204188 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaboration Revenue | 35,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Grant | 691,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 35,000,000 | USD | 0001193125-26-048957 |
| FY 2024Yearly · 2024-12-31 | Product | Grant | 2,314,000 | USD | 0001193125-26-048957 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenue | 0 | USD | 0001193125-25-273337 |
| Q3 2024Quarterly · 2024-09-30 | Product | Grant | 602,000 | USD | 0001193125-25-273337 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenue | 370,000,000 | USD | 0001193125-26-048957 |
| FY 2023Yearly · 2023-12-31 | Product | Grant | 1,206,000 | USD | 0001193125-26-048957 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Revenue | 436,000 | USD | 0000950170-25-017899 |
| FY 2022Yearly · 2022-12-31 | Product | Grant | 762,000 | USD | 0000950170-25-017899 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Revenue | 913,081,000 | USD | 0000950170-24-017571 |
| FY 2021Yearly · 2021-12-31 | Product | Grant | 1,882,000 | USD | 0000950170-24-017571 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration Revenue | 543,000 | USD | 0000950170-23-003441 |
| FY 2020Yearly · 2020-12-31 | Product | Grant | 176,000 | USD | 0000950170-23-003441 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.